CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…
STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…
SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the…
SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…
Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction…
Over 4,000 GMP Capsules Ready to Support PTSD Treatment in Australia, Israel, and CanadaVancouver, British Columbia--(Newsfile Corp. - January 29,…
AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that…
CRSA Joins Ryght Research Network to Accelerate Access to Novel Cancer Therapies LAGUNA BEACH, Calif., Jan. 28, 2025 /PRNewswire/ -- Ryght…
Collaborating to position the Cincinnati region as a top destination for advanced brain tumor care and innovation CINCINNATI, Jan. 28,…
FREMONT, Calif., Jan. 28, 2025 /PRNewswire/ -- Automating data capture by leveraging electronic health records can significantly improve data quality…